Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 702

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 4
Chunk 702
---
 1, 2023, we maintain a 401(k) retirement savings plan that allows eligible employees to contribute a portion of their compensation,
within limits prescribed by the Internal Revenue Code, on a pre-tax basis through contributions to the plan. Our named executive officers
are eligible to participate in the 401(k) plan. We believe that providing a vehicle for tax-deferred retirement savings through our 401(k)
plan adds to the overall desirability of our executive compensation package and further incentivizes our named executive officers in
accordance with our compensation policies.

Employee
Benefits and Perquisites

Our
named executive officers are eligible to participate in our health and welfare plans. We pay for the health and welfare benefits of our
named executive officers. We do not provide our named executive officers with any other significant perquisites or other personal benefits.

No
Tax Gross-Ups

We
do not make gross-up payments to cover our named executive officers’ personal income taxes that may pertain to any of the compensation
paid or provided by our company.

83

Outstanding
Equity Awards at Fiscal Year-End

The
following table sets forth information concerning outstanding option awards as of December 31, 2024, for each named executive officer:

Option
Awards

    Name
     
    Grant
    Date

    Number
    of Securities Underlying Unexercised
    Options Exercisable
    (#)

    Number
    of Securities Underlying Unexercised
    Options
    Unexercisable
    (#)

    Equity
    incentive
    plan awards: Number of
    securities
    underlying
    unexercised
    unearned
    options exercise price
    (#)

    Option
    Exercise Price
    ($)

    Option
    Expiration
    
    Date(1)

    Jeffrey
    A. Meckler, Chief Executive Officer
     
    04/10/17

    1,500

    —

    —

    425.6

    04/10/27

    05/01/17

    813

    —

    —

    425.6

    05/01/27

    12/11/17

    4,750

    —

    —

    536.0

    12/11/27

    06/28/18

    1,250

    —

    —

    355.2